FDA cleared the DLP Coronary Ostial Cannulae from Medtronic, Inc. on Oct 29, 2026 under K263596, a special 510(k). The device falls under product code DWF, Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass, regulated at 21 CFR 870.4210 as a Class 2 device. The review panel was Cardiovascular.
FDA logged the submission as received on Sep 30, 2026. The decision came 29 days later, inside the 90 FDA-day goal for a 510(k).
Medtronic, Inc. has 8 other decisions in the tracker over the last 12 months: K261792 (DLP PVC Left Heart Vent; DLP Malleable PVC Left Heart Vent; DLP Silicone Left Heart Vent), K262913 (Protégé EverFlex Self-expanding Peripheral Stent System), K262735 (LINQ II Insertable Cardiac Monitor (ICM) (LNQ22)), K262005 (Affera Integrated Mapping System).